Dr. Mebea Aklilu
Claim this profileAdvocate Illinois Masonic Medical Center
Studies Lung Cancer
Studies Colorectal Cancer
5 reported clinical trials
29 drugs studied
Area of expertise
1Lung Cancer
Stage I
Stage II
Stage III
2Colorectal Cancer
dMMR negative
MSI-H negative
Stage IV
Affiliated Hospitals
Clinical Trials Mebea Aklilu is currently running
Genetic Testing
for Early-Stage Lung Cancer
This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.
Recruiting0 awards N/A4 criteria
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
More about Mebea Aklilu
Clinical Trial Related5 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Mebea Aklilu has experience with
- Leucovorin Calcium
- Fluorouracil
- Irinotecan Hydrochloride
- Irinotecan
- Bevacizumab
- Cholecalciferol
Breakdown of trials Mebea Aklilu has run
Lung Cancer
Colorectal Cancer
Stomach Cancer
Non-Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Mebea Aklilu specialize in?
Mebea Aklilu focuses on Lung Cancer and Colorectal Cancer. In particular, much of their work with Lung Cancer has involved Stage I patients, or patients who are Stage II.
Is Mebea Aklilu currently recruiting for clinical trials?
Yes, Mebea Aklilu is currently recruiting for 2 clinical trials in Chicago Illinois. If you're interested in participating, you should apply.
Are there any treatments that Mebea Aklilu has studied deeply?
Yes, Mebea Aklilu has studied treatments such as Leucovorin Calcium, Fluorouracil, Irinotecan Hydrochloride.
What is the best way to schedule an appointment with Mebea Aklilu?
Apply for one of the trials that Mebea Aklilu is conducting.
What is the office address of Mebea Aklilu?
The office of Mebea Aklilu is located at: Advocate Illinois Masonic Medical Center, Chicago, Illinois 60657 United States. This is the address for their practice at the Advocate Illinois Masonic Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.